Navigation Links
New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
Date:8/31/2007

CAIRNS, Australia, Aug. 31 /PRNewswire/ --

What and When

Data from a six-month study of ramelteon will be presented in poster format at worldsleep07: The 5th World Congress of the World Federation of Sleep Research and Sleep Medicine Societies to be held in Cairns, Australia September 2-6, 2007. This large clinical study demonstrated that ramelteon was effective in reducing time to fall asleep for up to six months versus placebo in adult patients with chronic insomnia.

A total of 451 patients age 18 or older with chronic insomnia were randomized in this clinical study. Patients were given a nighttime dose of ramelteon 8 mg or placebo for up to 24 consecutive weeks with assessments performed after week one and months one, three, five and six of treatment.

Study results revealed consistent and statistically significant improvements in time to sleep onset using objective assessment via polysomnography -- a test that records brain activity and other body functions during sleep. Long-term use of ramelteon 8 mg was well tolerated and showed no evidence of next-day residual effects, pharmacological tolerance, rebound insomnia or withdrawal symptoms.

Poster 525 will be presented on Monday, September 3, 4:00 - 6:00 p.m.

Australian Eastern Standard Time To arrange an interview with Steven Sainati, please contact Amy Losak at

646-935-3917

Ramelteon is marketed by Takeda Pharmaceuticals North America, Inc. in the United States as ROZEREM(TM)(ramelteon).

About ROZEREM

ROZEREM(TM) (ramelteon) is indicated for the treatment of insomnia characterized by difficulty with sleep onset. ROZEREM can be prescribed for long-term use. ROZEREM is the first and only prescription sleep medication that has shown no evidence of abuse or dependence in clinical studies,* and has not been designated as a controlled substance. With the exception of ROZEREM, all other prescription me
'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... LONDON and NEW YORK ... http://www.abmrg.com/Indonesia-Respiratory-Devices-and-Respiratory-Diagnostics-Market-through-2020---Detailed-analysis-of-Hospital-and-Retail-market.html - Over 70% Indonesian men ... 400,000 Indonesians die annually due to smoking-related conditions; of ... of 6.5 million vehicles in Jakarta ... Indonesia is the fourth most ...
(Date:5/27/2015)... 27, 2015 The Bio-Process Systems Alliance ... Annual International Single-Use Summit (ISUS 2015) will be ... , with a primary focus on the promises ... From technical topics to business and regulatory presentations, ... the emergence of the single-use industry as the "go-to" ...
(Date:5/27/2015)... OKLAHOMA CITY , May 27, 2015  Foundation ... on surgeries and related ancillary services, announced today it ... be held June 1-3, 2015 at Luxe Sunset Boulevard ... will be presenting on Tuesday, June 2 nd ... meetings. To schedule a one-on-one meeting please contact LD ...
Breaking Medicine Technology:Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 2Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 3Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 4BPSA's 5th Annual Summit to Provide '2020 Vision' for Single-Use Technologies 2BPSA's 5th Annual Summit to Provide '2020 Vision' for Single-Use Technologies 3
(Date:5/27/2015)... May 27, 2015 Genius Monkey is ... advanced programmatic marketing technology, they have boosted sales for ... on a regional level for seven Utah-based dealers. ... through television and radio media. In 2014 the Utah ... help of Genius Monkey , shifted their marketing ...
(Date:5/27/2015)... Francisco, CA (PRWEB) May 27, 2015 With ... a total communication environment where the message is not only ... a toy, drawing, or virtually any motivating image. This award-winning ... has to offer. , Now, using InnerVoice Sender ... messages can be sent to a learner remotely for no ...
(Date:5/27/2015)... 2015 With a prevalently high rate ... during the "ACA - Controlling the Chaos" webinar revealed ... currently in the process of researching ACA solution ... prepared for the reporting mandates. , According to a ... those who are currently vetting ACA reporting solutions are ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 SmarterSkin, http://www.smarterskindermatology.com ... with a cutting-edge test that makes it easier for patients ... skin type. , Dr. Sejal Shah is a cosmetic ... in NYC to offer the test. This revolutionary DNA test ... associated with skin aging: , 1. Firmness and ...
(Date:5/27/2015)... Decorview , a leading seller ... free design advice to homeowners looking to , combat ... pollution caused by streetlights, outdoor signs, full moons and ... said Kim Rush, VP of sales and merchandising for ... America with recently installed LED streetlights– the blue glare ...
Breaking Medicine News(10 mins):Health News:Genius Monkey Boosts Utah Honda Dealers Website Traffic 142% 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 3Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 4Health News:Employers are On Track for ACA Reporting According to Businessolver Poll 2Health News:SmarterSkin Dermatology is Now Offering Skin DNA Analysis 2Health News:Decorview Helps Homeowners Combat Light Pollution 2
... change after 30-minute psychosocial intervention, study finds , FRIDAY, ... persistent drunk drivers to consider why they should stop ... changes, researchers have found. , The new study included ... convictions, who were randomly assigned to one of two ...
... , , BEDFORD, Mass., Nov. 27 ... of precision technology products and semiconductor systems, today announced that ... for Friday, April 30, 2010. The time and location ... As previously announced, the Company received a requisition notice from ...
... , DALLAS, Nov. 27 Considered a highly risky ... transplantation is now a life-saving mainstream operation thanks to the ... House in Dallas on Nov. 11. Leaders came together from ... of Baylor Regional Transplant Institute (BRTI), one of the pioneers ...
... , NEUILLY-SUR-SEINE, France, Nov. 27 ... dedicated to ethical sporting and developing the next generation ... Team Garmin-Transitions with the addition of Transitions Optical as ... the world,s leading manufacturer of adaptive eyewear, offering the ...
... low-emission vehicles may reduce future disease burden, researchers say ... dwellers to walk and bicycle instead of using cars ... used of low-emission vehicles, U.K. researchers have found. , ... of alternative urban land transport scenarios for London, England, ...
... ... announced today that Spectrum Health (Grand Rapids, Michigan) has licensed its TraumaCad Enterprise ... ... -- Voyant Health™ announced today that Spectrum Health (Grand Rapids, Michigan) has licensed ...
Cached Medicine News:Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:GSI Group Calls Shareholders Meeting 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3